PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMPH.L Regulatory News (MPH)

  • There is currently no data for MPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Finance Director Appointment

10 Mar 2008 12:08

Marchpole Holdings PLC10 March 2008 MARCHPOLE HOLDINGS PLC ("Marchpole" or "the Company") Appointment of Finance Director Marchpole Holdings plc, (LSE: MPH), the fashion brand management group, ispleased to announce that John Macaulay has been appointed Group FinanceDirector. John, who was Group Financial Officer, will join the Board withimmediate effect. Ray Harris, who has been Acting Finance Director since July 2007, will continueas an Executive Director on the Board. Most recently John was Group Finance Director of AIM listed Creative EducationPlc, before joining Marchpole in July 2007. Prior to his role at CreativeEducation, John was Group Finance Director for International Clothing DesignLtd, a privately owned clothing group involved in the design, sourcing andmanufacture of clothes with operations throughout Europe and the Far East. The following information falls to be disclosed regarding the appointment underLR 9.6.13: John Arnold Macaulay (dob: 23.02.1957) (1) Directorships (of publically quoted companies within the last five years) CEC plc - resigned 17.08.2007 (3) Receiverships. liquidations, administrations Company Nature of Shares Company Date Date Date of Event Business Listed Number appointed resigned CEC plc and its Nursery/ 04293530 01.04.2006 17.08.2007 Administrationsubsidiaries Education 17.08.2007 YesVaco Clothing 2643507 31.12.2001 06.05.2003 Creditors'(International) Supplier VoluntaryLtd No liquidation 26.11.2003 Harland Simon Computer/Bus Yes 1963605 10.11.1990 07.05.1992 ReceivershipGroup plc Services 10.1992 No further information is required to be disclosed under items (2) and (4-6) ofLR 9.6.13. Michael Morris, Executive Deputy Chairman of Marchpole commented: "I amdelighted that John Macaulay has agreed to become Group Finance Director. I lookforward to welcoming John to the Board in his role. John, in his former role atInternational Clothing Design, has gained unrivalled experience in our industryand we look forward to benefiting from that knowledge. Furthermore, I would liketo thank Ray Harris for all his support particularly during the last 5 months asActing Finance Director, and we will continue to benefit from his experience inhis capacity as an Executive Director. Collectively, we look forward to the next stage of the Company's development andthe Board is committed to delivering solid growth and better shareholder valueover the medium to long term". - ends - For further information, please contact: Bell Pottinger Corporate & Financial 020 7861 3232David Rydell/Emma Kent/Amy Rajendran Marchpole Holdings plc 020 7908 7777Michael Morris, Executive Deputy Chairman Note to Editors: - Marchpole Holdings plc ("Marchpole") is an international brand management group that designs, produces and sells clothing and accessories for ten globally recognised fashion labels. It operates in all of the world's mainmarkets - UK, mainland Europe, Middle East, Asia and the USA - Its respected brands include Boateng, Emanuel Ungaro, Ungaro Homme,Jean Charles de Castelbajac ("JCC"), Jean Charles de Castelbajac / Rossignol,Jean Charles de Castelbajac/Okaidi, Jean Charles de Castelbajac / New Era, JCDC/Lee Cooper and Homebody and Homemummy - Marchpole is renowned for its integrated approach to brand management, taking a brand from concept to design studio to the customerinterface. - The Group has grown considerably in the past four years, from alicensee with one core licence (YSL menswear) - to today's internationalbusiness that manages its brands across a multitude of clothing lines andaccessories - Marchpole's acquisition (March 2006) of Moda America - the US licensee for leading designer Emanuel Ungaro - provided further growth opportunities in the UK and America and strengthened the Company's relationship with Ungaro - The acquisition also enabled the Company to launch the Ungaro brand,already established by Marchpole in Europe and Asia, into the US, Canada andSouth America. The acquisition has also enabled the Company to re-launch JCCinto America. - In March 2007 Marchpole acquired 100% of Greenmark Limited, an importer and wholesaler of ladies shoes who currently supply in excess of 2.5 million pairs of shoes per annum. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
11th Feb 20197:00 amRNSBoard Change
25th Jan 201911:10 amRNSPublication of F-4
18th Jan 20197:00 amRNSNew Deferred Bonus Plan
15th Jan 20197:00 amRNSBGS-649 Phase 2b data to be Presented at ENDO 2019
27th Dec 201810:02 amRNSDirector/PDMR Shareholding
24th Dec 20187:00 amRNSDirector/PDMR Shareholding
18th Dec 20187:00 amRNSPositive results from safety extension study
17th Dec 20186:25 pmRNSPositive results from safety extension study
17th Dec 20183:44 pmRNSAIM Rule 17 Disclosure Statement
10th Dec 20187:00 amRNSPresentation at BMO Healthcare Conference
5th Dec 20181:09 pmRNSProposed combination of Mereo and OncoMed
26th Nov 20187:00 amRNSIssue of Warrants
5th Nov 20187:00 amRNSFirst patient dosed in Phase 2 study
31st Oct 20183:37 pmRNSTotal Voting Rights
15th Oct 20187:00 amRNSCompletion of Patient Enrolment in Phase 2b study
1st Oct 201810:00 amRNSRevised Credit Facility and Issue of Warrants
3rd Sep 20187:00 amRNSBlock Listing Application
31st Aug 20186:25 pmRNSCorrection to Issued Share Capital
8th Aug 20187:00 amRNSMereo BioPharma Interim Results 2018
23rd Jul 20187:00 amRNSNotice of Interim Results
23rd Jul 20187:00 amRNSExercise of Options
21st Jun 201812:52 pmRNSResult of Annual General Meeting
29th May 20187:00 amRNSSuccessful Completion of PrimaryBid Offer
25th May 20184:31 pmRNSPrimaryBid.com Offer
22nd May 20187:00 amRNSNotice of AGM
27th Apr 20187:00 amRNSGrant of Options
26th Apr 20187:00 amRNSUpdate on Offering & Application to List on Nasdaq
9th Apr 201811:34 amRNSOffering and Application to List on Nasdaq
6th Apr 20181:03 pmRNSResult of General Meeting
3rd Apr 20187:00 amRNSPublication of Annual Report
26th Mar 20187:00 amRNSMereo BioPharma Files for Proposed Global Offering
23rd Mar 20187:00 amRNSFinal Results
20th Mar 20187:00 amRNSMereo selected for oral presentation at ATS 2018
20th Mar 20187:00 amRNSPUBLICATION OF NOTICE OF GENERAL MEETING
19th Mar 20187:00 amRNSMereo: Positive Top-Line Results for BGS-649
26th Feb 20187:00 amRNSMereo BioPharma Appoints Wills Hughes-Wilson
2nd Jan 20187:00 amRNS£10m credit facility drawdown & issue of warrants
18th Dec 20177:00 amRNSMereo Plans to Conduct Registered IPO in the US
13th Dec 20177:00 amRNSMereo BioPharma: Business Update
11th Dec 20177:00 amRNSPositive results from Phase 2 trial with BCT-197
13th Nov 20177:00 amRNSBPS-804 receives PRIME designation
6th Nov 201712:19 pmRNSHolding(s) in Company
30th Oct 20177:00 amRNSMereo announces agreement with AstraZeneca
18th Sep 20177:00 amRNSMereo to Present at Cantor Healthcare Conference
5th Sep 20177:00 amRNSUpdate on BGS-649 Phase 2b Study
22nd Aug 20179:17 amRNSIssue of Warrants
8th Aug 20177:12 amRNSInterim Results
3rd Jul 20177:00 amRNSNotice of Results
27th Jun 201711:23 amRNSResult of AGM
15th May 20177:00 amRNSUpdate on acumapimod Phase 2 Study

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.